Brian Gorman - Net Worth and Insider Trading

Brian Gorman Net Worth

The estimated net worth of Brian Gorman is at least $660,594 dollars as of 2024-05-02. Brian Gorman is the General Counsel of Opiant Pharmaceuticals Inc and owns about 31,990 shares of Opiant Pharmaceuticals Inc (OPNT) stock worth over $660,594. Details can be seen in Brian Gorman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Brian Gorman has not made any transactions after 2023-01-27 and currently still holds the listed stock(s).

Transaction Summary of Brian Gorman

To

Brian Gorman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brian Gorman owns 1 companies in total, including Opiant Pharmaceuticals Inc (OPNT) .

Click here to see the complete history of Brian Gorman’s form 4 insider trades.

Insider Ownership Summary of Brian Gorman

Ticker Comapny Transaction Date Type of Owner
OPNT Opiant Pharmaceuticals Inc 2023-01-27 other: General Counsel

Brian Gorman Latest Holdings Summary

Brian Gorman currently owns a total of 1 stock. Brian Gorman owns 31,990 shares of Opiant Pharmaceuticals Inc (OPNT) as of January 27, 2023, with a value of $660,594.

Latest Holdings of Brian Gorman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OPNT Opiant Pharmaceuticals Inc 2023-01-27 31,990 20.65 660,594

Holding Weightings of Brian Gorman


Brian Gorman Form 4 Trading Tracker

According to the SEC Form 4 filings, Brian Gorman has made a total of 5 transactions in Opiant Pharmaceuticals Inc (OPNT) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in Opiant Pharmaceuticals Inc is the sale of 444 shares on January 27, 2023, which brought Brian Gorman around $8,995.

Insider Trading History of Brian Gorman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Brian Gorman Trading Performance

GuruFocus tracks the stock performance after each of Brian Gorman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Brian Gorman is 67.61%. GuruFocus also compares Brian Gorman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Brian Gorman within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Brian Gorman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Brian Gorman

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 27.56
Relative Return to S&P 500(%) 27.67

Brian Gorman Ownership Network

Ownership Network List of Brian Gorman

No Data

Ownership Network Relation of Brian Gorman


Brian Gorman Owned Company Details

What does Opiant Pharmaceuticals Inc do?

Who are the key executives at Opiant Pharmaceuticals Inc?

Brian Gorman is the other: General Counsel of Opiant Pharmaceuticals Inc. Other key executives at Opiant Pharmaceuticals Inc include Chief Scientific Officer Phil Skolnick , director & 10 percent owner & Chief Executive Officer Roger Crystal , and other: UK Managing Director Ellison Mark Jason Heath .

Opiant Pharmaceuticals Inc (OPNT) Insider Trades Summary

Over the past 18 months, Brian Gorman made 2 insider transaction in Opiant Pharmaceuticals Inc (OPNT) with a net sale of 1,757. Other recent insider transactions involving Opiant Pharmaceuticals Inc (OPNT) include a net sale of 7,570 shares made by Roger Crystal , a net sale of 2,885 shares made by Ellison Mark Jason Heath , and a net sale of 2,556 shares made by David D O'toole .

In summary, during the past 3 months, insiders sold 0 shares of Opiant Pharmaceuticals Inc (OPNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,038 shares of Opiant Pharmaceuticals Inc (OPNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 17,038 shares.

Opiant Pharmaceuticals Inc (OPNT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Opiant Pharmaceuticals Inc Insider Transactions

No Available Data

Brian Gorman Mailing Address

Above is the net worth, insider trading, and ownership report for Brian Gorman. You might contact Brian Gorman via mailing address: 233 Wilshire Blvd, Suite 280, Santa Monica Ca 90401.

Discussions on Brian Gorman

No discussions yet.